Novartis inks settlements worth $347M with DOJ, SEC over foreign doctor payments, records keeping

Novartis has faced years of investigations into its overseas conduct, including kickbacks probes in Greece and South Korea. Now, it’s admitting it paid doctors to use more of its products in certain countries—and agreed to pay $347 million for violating the U.S. Foreign Corrupt Practices Act.